587
Views
185
CrossRef citations to date
0
Altmetric
Review

Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges

, PhD (Postdoctoral Fellow) , , PhD (Postdoctoral Fellow) & , PhD (Senior Investigator & Chief, Transport Biochemistry Section)
Pages 205-223 | Published online: 05 Feb 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Haiyan Gao, Yan Bai, Lijuan Chen, Georges Ei Fakhri & Meiyun Wang. (2020) Self-Assembly Nanoparticles for Overcoming Multidrug Resistance and Imaging-Guided Chemo-Photothermal Synergistic Cancer Therapy. International Journal of Nanomedicine 15, pages 809-819.
Read now
Sukanya Unson, Chanaporn Kongsaden & Piyanuch Wonganan. (2020) Cepharanthine combined with 5-fluorouracil inhibits the growth of p53-mutant human colorectal cancer cells. Journal of Asian Natural Products Research 22:4, pages 370-385.
Read now
Aysegul Cort & Tomris Ozben. (2015) Natural Product Modulators to Overcome Multidrug Resistance In Cancer. Nutrition and Cancer 67:3, pages 411-423.
Read now
Siyuan Sun, Zhongjian Chen, Liping Li, Dongli Sun, Ye Tian, Hao Pan, Huichang Bi, Min Huang, Su Zeng & Huidi Jiang. (2012) The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. Xenobiotica 42:12, pages 1197-1205.
Read now
Ping He, Hua Sun, Xi-Xian Jian, Qiao-Hong Chen, Dong-Lin Chen, Geng-Tao Liu & Feng-Peng Wang. (2012) Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer. Journal of Asian Natural Products Research 14:6, pages 564-576.
Read now
Naseem Akhtar, Abdul Ahad, Roop Kishan Khar, Manu Jaggi, Mohammed Aqil, Zeenat Iqbal, Farhan Jalees Ahmad & Sushama Talegaonkar. (2011) The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opinion on Therapeutic Patents 21:4, pages 561-576.
Read now
Yan Li, Jezrael L. Revalde, Glen Reid & James W. Paxton. (2010) Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews 42:4, pages 590-611.
Read now
Dong Il Kang, He-Kyung Kang, Hye-Sun Gwak, Hyo-Kyung Han & Soo-Jeong Lim. (2009) Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells. Drug Delivery 16:5, pages 261-267.
Read now

Articles from other publishers (177)

Lisandro Alberto Encalada-Mena, Raquel López-Arellano, María Eugenia López-Arellano, María Gabriela Mancilla-Montelongo, Carlos Alfredo Sandoval-Castro, Agustín Olmedo-Juárez, Adrián Lifschitz & Juan Felipe de Jesús Torres-Acosta. (2023) Curcumin-PVP improves the in vitro efficacy of ivermectin against resistant and susceptible Haemonchus contortus. Experimental Parasitology, pages 108670.
Crossref
Chung-Pu Wu, Megumi Murakami, Yen-Ching Li, Yang-Hui Huang, Yu-Tzu Chang, Tai-Ho Hung, Yu-Shan Wu & Suresh V. Ambudkar. (2023) Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport. Pharmaceuticals 16:11, pages 1595.
Crossref
Andaleeb Sajid, Hadiar Rahman & Suresh V. Ambudkar. (2023) Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters. Nature Reviews Cancer 23:11, pages 762-779.
Crossref
Hung Wei Lai, Yukitaka Tani, Udomlak Sukatta, Prapassorn Rugthaworn, Asada Thepyos, Shinkuro Yamamoto, Hideo Fukuhara, Keiji Inoue, Hideya Yuasa, Hiroyuki Nakamura & Shun-ichiro Ogura. (2023) Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity. Photodiagnosis and Photodynamic Therapy, pages 103798.
Crossref
Sungpil Yoon & Hyung Sik Kim. (2023) First-Line Combination Treatment with Low-Dose Bipolar Drugs for ABCB1-Overexpressing Drug-Resistant Cancer Populations. International Journal of Molecular Sciences 24:9, pages 8389.
Crossref
Sumel Ashique, Ashish Garg, Afzal Hussain, Shvetank Bhatt, Ankur Agrawal & Neeraj Mishra. 2023. Polymeric Micelles: Principles, Perspectives and Practices. Polymeric Micelles: Principles, Perspectives and Practices 231 251 .
Elisabetta Teodori, Laura Braconi, Dina Manetti, Maria Novella Romanelli & Silvia Dei. (2022) The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers. Current Topics in Medicinal Chemistry 22:31, pages 2535-2569.
Crossref
Alessandra Amendolare, Flaviana Marzano, Vittoria Petruzzella, Rosa Anna Vacca, Luisa Guerrini, Graziano Pesole, Elisabetta Sbisà & Apollonia Tullo. (2022) The Underestimated Role of the p53 Pathway in Renal Cancer. Cancers 14:23, pages 5733.
Crossref
Yan-Qing Li, Megumi Murakami, Yang-Hui Huang, Tai-Ho Hung, Shun-Ping Wang, Yu-Shan Wu, Suresh V. Ambudkar & Chung-Pu Wu. (2022) Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells. International Journal of Molecular Sciences 23:21, pages 12763.
Crossref
ISHA SHAH & JIGAR VYAS. (2022) ROLE OF P-GP INHIBITORS ON GUT PERMEATION OF METFORMIN: AN EX-VIVO STUDY. International Journal of Pharmacy and Pharmaceutical Sciences, pages 18-23.
Crossref
Chung-Pu Wu, Ya-Ju Hsieh, Han-Yu Tseng, Yang-Hui Huang, Yan-Qing Li, Tai-Ho Hung, Shun-Ping Wang & Yu-Shan Wu. (2022) The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2. Biomedicine & Pharmacotherapy 154, pages 113663.
Crossref
Chung-Pu Wu, Megumi Murakami, Yu-Shan Wu, Chun-Ling Lin, Yan-Qing Li, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2022) The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs. Biomedicine & Pharmacotherapy 149, pages 112922.
Crossref
Yunmoon Oh, Jin-Sol Lee, Ji Sun Lee, Jae Hyeon Park, Hyung Sik Kim & Sungpil Yoon. (2022) JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells. International Journal of Molecular Sciences 23:9, pages 4597.
Crossref
Wei Shi, Ping Zhang, Feng Zou, Jiaqi Zhou, Ziyu Yin, Zilong Cai, Hesham Ghaleb, Yuxuan Jiang, Wenlong Huang, Yan Liu, Qianqian Qiu & Hai Qian. (2022) Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel. European Journal of Medicinal Chemistry 233, pages 114231.
Crossref
Xing Chang, Zi Liu, Simeng Cao, Jiang Bian, Dayong Zheng, Nuo Wang, Qi Guan, Yingliang Wu, Weige Zhang, Zengqiang Li & Daiying Zuo. (2022) Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis. Toxicology and Applied Pharmacology 436, pages 115883.
Crossref
Shrey Shah, Miller Ouellette & Gerard G. M. D’Souza. (2022) In vitro assessment of stearyl triphenyl phosphonium toxicity in drug-resistant tumor cells. 4open 5, pages 6.
Crossref
Tarun Sahu, Arundhati Mehta, Henu Kumar Verma & L.V.K.S. Bhaskar. 2022. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 227 253 .
Parul Sharma, Navneet Singh & Siddharth Sharma. (2021) ATP binding cassette transporters and cancer: revisiting their controversial role. Pharmacogenomics 22:18, pages 1211-1235.
Crossref
Burak YAZGAN, Seda MESCİ, Maşuk AKŞAHIN, Arif AYAR, Melek GÜL & Tuba YILDIRIM. (2021) ATP‐Binding Cassette Transporters Mediated Chemoresistance in MCF-7 Cells: Modulation by PhTAD-Substituted Dihydropyrrole Compounds. Ahi Evran Medical Journal.
Crossref
Chung-Pu Wu, Yan-Qing Li, Tai-Ho Hung, Yu-Tzu Chang, Yang-Hui Huang & Yu-Shan Wu. (2021) Sophoraflavanone G Resensitizes ABCG2-Overexpressing Multidrug-Resistant Non-Small-Cell Lung Cancer Cells to Chemotherapeutic Drugs. Journal of Natural Products 84:9, pages 2544-2553.
Crossref
Anna Palko-Łabuz, Maria Błaszczyk, Kamila Środa-Pomianek & Olga Wesołowska. (2021) Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter. Molecules 26:15, pages 4637.
Crossref
Chung-Pu Wu, Megumi Murakami, Yu-Shan Wu, Ya-Chen Chi, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2021) Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents. Frontiers in Cell and Developmental Biology 9.
Crossref
Xu Wu, Chun Yin, Jiang Ma, Stella Chai, Chunyuan Zhang, Sheng Yao, Onat Kadioglu, Thomas Efferth, Yang Ye, Kenneth Kin-Wah To & Ge Lin. (2021) Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo. Acta Pharmaceutica Sinica B 11:7, pages 1885-1902.
Crossref
Chung-Pu Wu, Tai-Ho Hung, Sabrina Lusvarghi, Yi-Hsuan Chu, Sung-Han Hsiao, Yang-Hui Huang, Yu-Tzu Chang & Suresh V. Ambudkar. (2021) The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs. Biochemical Pharmacology 188, pages 114516.
Crossref
Sharad S Singhal, Atish Mohanty, Prakash Kulkarni, David Horne, Sanjay Awasthi & Ravi Salgia. (2021) RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells. Carcinogenesis 42:5, pages 742-752.
Crossref
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, Charles R. AshbyJrJr, Yehuda G. Assaraf, Zhe-Sheng Chen & Abhijit Dey. (2021) Therapeutic strategies to overcome taxane resistance in cancer. Drug Resistance Updates 55, pages 100754.
Crossref
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Linlin Yang, Zi-Ning Lei, Xiao-Han Yuan, Jun-Feng Huo, Xiao-Bing Chen, Mengru Wang, Bin Yu, Zhe-Sheng Chen & Hong-Min Liu. (2020) Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5- a ]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators . Journal of Medicinal Chemistry 63:24, pages 15979-15996.
Crossref
Jun Wan, Xie‐an Ling, Jian Wang, Guang‐gui Ding & Xi Wang. (2020) Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P‐glycoprotein expression level in non‐small lung cancer. Journal of Cellular and Molecular Medicine 24:21, pages 12840-12847.
Crossref
Kamalani Achala H. Hewage, Jing‐Fang Yang, Di Wang, Ge‐Fei Hao, Guang‐Fu Yang & Jian‐Kang Zhu. (2020) Chemical Manipulation of Abscisic Acid Signaling: A New Approach to Abiotic and Biotic Stress Management in Agriculture. Advanced Science 7:18.
Crossref
Liang Peng, Ding-Qiang Chen, Guan-Ming Jiang, Jing-Yi Ou, Qiao Jiang, Li-Ting Zeng, Yi Xiao, Qiong-Yan Jiang, Ling Yang & Ning Sun. (2020) Transcriptome Analysis of Two Strains of Proteus mirabilis with Swarming Migration Deficiency Isolated from Patients with Urinary Tract Infection. Current Microbiology 77:8, pages 1381-1389.
Crossref
Xiaoli Zeng, Xu Cheng, Yan Zheng, Guoqing Yan, Xin Wang, Jun Wang & Rupei Tang. (2020) Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer. Carbohydrate Polymers 237, pages 116139.
Crossref
Chung-Pu Wu, Tai-Ho Hung, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Shun-Ping Wang & Yu-Shan Wu. (2020) Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Cancers 12:6, pages 1366.
Crossref
Chung-Pu Wu, Sabrina Lusvarghi, Sung-Han Hsiao, Te-Chun Liu, Yan-Qing Li, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2020) Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. Journal of Natural Products 83:5, pages 1461-1472.
Crossref
Kyeong Seok Kim, Chunxue Jiang, Ji Young Kim, Jae Hyeon Park, Hae Ri Kim, Su Hyun Lee, Hyung Sik Kim & Sungpil Yoon. (2020) Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro. Frontiers in Oncology 10.
Crossref
Olga Wesołowska, Krystyna Michalak, Maria Błaszczyk, Joseph Molnár & Kamila Środa-Pomianek. (2020) Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells. Molecules 25:7, pages 1654.
Crossref
Xu Cheng, Xiaoli Zeng, Yan Zheng, Qin Fang, Xin Wang, Jun Wang & Rupei Tang. (2020) pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy. Journal of Colloid and Interface Science 565, pages 254-269.
Crossref
Sophie E. B. Ambjørner, Michael Wiese, Sebastian Christoph Köhler, Joen Svindt, Xamuel Loft Lund, Michael Gajhede, Lasse Saaby, Birger Brodin, Steffen Rump, Henning Weigt, Nils Brünner & Jan Stenvang. (2020) The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP. Cells 9:3, pages 613.
Crossref
Tatjana P. Stanojkovic & Sanja Milovic. (2020) A Marine Natural Products as Modulators of Multidrug Resistance. Journal of Cancer Research Updates 9:1, pages 96-101.
Crossref
Chung-Pu Wu, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Tai-Ho Hung & Yu-Shan Wu. (2020) Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. Cancers 12:1, pages 195.
Crossref
Jose J.G. Marin, Rocio I.R. Macias, Elisa Herraez, Elisa Lozano, Marta R. Romero, Silvia Di Giacomo, Thomas Efferth & Oscar Briz. 2020. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy 197 250 .
Chung-Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2019) The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences 21:1, pages 238.
Crossref
Jing-Quan Wang, Bo Wang, Zi-Ning Lei, Qiu-Xu Teng, Jonathan Y. Li, Wei Zhang, Ning Ji, Chao-Yun Cai, Li-Ying Ma, Hong-Min Liu & Zhe-Sheng Chen. (2019) Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance. European Journal of Pharmacology 863, pages 172611.
Crossref
Ronilda R. D’Cunha, Daryl J. Murry & Guohua An. (2019) Nilotinib Alters the Efflux Transporter-Mediated Pharmacokinetics of Afatinib in Mice. Journal of Pharmaceutical Sciences 108:10, pages 3434-3442.
Crossref
Shirin Mollazadeh, Amirhossein Sahebkar, Fatemeh Kalalinia, Javad Behravan & Farzin Hadizadeh. (2019) Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity. Bioorganic Chemistry 91, pages 103156.
Crossref
An, Ma, Du, Yu, Li, Luan, Jiang & Li. (2019) Preliminary Classification of the ABC Transporter Family in Betula halophila and Expression Patterns in Response to Exogenous Phytohormones and Abiotic Stresses. Forests 10:9, pages 722.
Crossref
Chung-Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2019) Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines. Molecular Pharmaceutics 16:7, pages 3040-3052.
Crossref
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania & María Laura Ruiz. (2019) ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 26:7, pages 1224-1250.
Crossref
Caixia Yang, Xin Pang, Weihai Chen, Xiaoyong Wang, Gan Lin, Chengchao Chu, Xianzheng Zhang, Xianming Deng, Xiaoyuan Chen & Gang Liu. (2019) Environmentally responsive dual-targeting nanotheranostics for overcoming cancer multidrug resistance. Science Bulletin 64:10, pages 705-714.
Crossref
Mengmeng Xia, Yajing Fang, Weiwei Cao, Fuqiang Liang, Siyi Pan & Xiaoyun Xu. (2019) Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells. Molecules 24:9, pages 1661.
Crossref
Sung-Han Hsiao, Sabrina Lusvarghi, Yang-Hui Huang, Suresh V. Ambudkar, Sheng-Chieh Hsu & Chung-Pu Wu. (2019) The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Cancer Letters 445, pages 34-44.
Crossref
Kamila Środa-Pomianek, Krystyna Michalak, Anna Palko-Łabuz, Anna Uryga, Piotr Świątek, Michał Majkowski & Olga Wesołowska. (2019) The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells. International Journal of Molecular Sciences 20:4, pages 955.
Crossref
Ning Ji, Yuqi Yang, Chao-Yun Cai, Zi-Ning Lei, Jing-Quan Wang, Pranav Gupta, Suneet Shukla, Suresh V. Ambudkar, Dexin Kong & Zhe-Sheng Chen. (2019) Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells. Cancer Letters 440-441, pages 82-93.
Crossref
Chung-Pu Wu & Sheng-Chieh Hsu. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy 169 185 .
Lei Zhang, Xian Zeng, Xiaodong Ren, Nengyin Tao, Chengli Yang, Yingshu Xu, Yongzheng Chen & Jing Wang. (2018) Design, synthesis, and biological evaluation of indole carboxylic acid esters of podophyllotoxin as antiproliferative agents. Medicinal Chemistry Research 28:1, pages 81-94.
Crossref
Haneen Amawi, Hong-May Sim, Amit K. Tiwari, Suresh V. Ambudkar & Suneet Shukla. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity 549 580 .
Liming Chang, Mengwu Xiao, Linlin Yang, Shuai Wang, Sai-Qi Wang, Andreas Bender, Aixi Hu, Zhe-Sheng Chen, Bin Yu & Hong-Min Liu. (2018) Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR). Bioorganic & Medicinal Chemistry 26:22, pages 5974-5985.
Crossref
Ning Ji, Yuqi Yang, Zi-Ning Lei, Chao-Yun Cai, Jing-Quan Wang, Pranav Gupta, Xiaomeng Xian, Dong-Hua Yang, Dexin Kong & Zhe-Sheng Chen. (2018) Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. Biochemical Pharmacology 158, pages 274-285.
Crossref
Ning Ji, Yuqi Yang, Chao-Yun Cai, Zi-Ning Lei, Jing-Quan Wang, Pranav Gupta, Qiu-Xu Teng, Zhe-Sheng Chen, Dexin Kong & Dong-Hua Yang. (2018) VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters. Frontiers in Pharmacology 9.
Crossref
Lurong Pan & Stephen G. Aller. (2018) Allosteric Role of Substrate Occupancy Toward the Alignment of P-glycoprotein Nucleotide Binding Domains. Scientific Reports 8:1.
Crossref
Sung-Han Hsiao, Megumi Murakami, Ni Yeh, Yan-Qing Li, Tai-Ho Hung, Yu-Shan Wu, Suresh V. Ambudkar & Chung-Pu Wu. (2018) The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines. Cancer Letters 434, pages 81-90.
Crossref
Chung-Pu Wu, Megumi Murakami, Sung-Han Hsiao, Te-Chun Liu, Ni Yeh, Yan-Qing Li, Tai-Ho Hung, Yu-Shan Wu & Suresh. V. Ambudkar. (2018) SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Letters 433, pages 259-272.
Crossref
Liming Chang, Mengwu Xiao, Linlin Yang, Shuai Wang, Sai-Qi Wang, Andreas Bender, Aixi Hu, Zhe-Sheng Chen, Bin Yu & Hong-Min Liu. (2018) Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR). Bioorganic & Medicinal Chemistry 26:18, pages 5006-5017.
Crossref
Bo Wang, Li-Ying Ma, Jing-Quan Wang, Zi-Ning Lei, Pranav Gupta, Yuan-Di Zhao, Zhong-Hua Li, Ying Liu, Xin-Hui Zhang, Ya-Nan Li, Bing Zhao, Zhe-Sheng Chen & Hong-Min Liu. (2018) Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance. Journal of Medicinal Chemistry 61:14, pages 5988-6001.
Crossref
Michael K. Krapf, Jennifer Gallus, Sahel Vahdati & Michael Wiese. (2018) New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold. Journal of Medicinal Chemistry 61:8, pages 3389-3408.
Crossref
Giovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, Valentina Zuco & Laura Gatti. (2017) Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents. European Journal of Medicinal Chemistry 142, pages 271-289.
Crossref
Katja Stefan, Sven Marcel Schmitt & Michael Wiese. (2017) 9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein. Journal of Medicinal Chemistry 60:21, pages 8758-8780.
Crossref
Chung-Pu Wu, Sung-Han Hsiao, Megumi Murakami, Ming-Jie Lu, Yan-Qing Li, Chia-Hung Hsieh, Suresh.V. Ambudkar & Yu-Shan Wu. (2017) Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Letters 409, pages 56-65.
Crossref
Ji Hyun Cheon, Kyeong Seok Kim, Dharmendra Kumar Yadav, Mihyun Kim, Hyung Sik Kim & Sungpil Yoon. (2017) The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochemical and Biophysical Research Communications 490:4, pages 1176-1182.
Crossref
Chung-Pu Wu, Sung-Han Hsiao, Megumi Murakami, Yu-Jen Lu, Yan-Qing Li, Yang-Hui Huang, Tai-Ho Hung, Suresh. V. Ambudkar & Yu-Shan Wu. (2017) Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter. Molecular Pharmaceutics 14:8, pages 2805-2814.
Crossref
Yi-Jun Wang, Yun-Kai Zhang, Guan-Nan Zhang, Sweilem B. Al Rihani, Meng-Ning Wei, Pranav Gupta, Xiao-Yu Zhang, Suneet Shukla, Suresh V. Ambudkar, Amal Kaddoumi, Zhi Shi & Zhe-Sheng Chen. (2017) Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study. Cancer Letters 396, pages 145-154.
Crossref
Elka R. Georgieva. (2017) Nanoscale lipid membrane mimetics in spin-labeling and electron paramagnetic resonance spectroscopy studies of protein structure and function. Nanotechnology Reviews 6:1, pages 75-92.
Crossref
Ladislav Sivak, Vladimir Subr, Jakub Tomala, Blanka Rihova, Jiri Strohalm, Tomas Etrych & Marek Kovar. (2017) Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate. Biomaterials 115, pages 65-80.
Crossref
K. Awasthi, Asmita Das & T. Prasad. 2017. Molecular Markers in Mycology. Molecular Markers in Mycology 335 352 .
Xiao-Yu Zhang, Yun-Kai Zhang, Yi-Jun Wang, Pranav Gupta, Leli Zeng, Megan Xu, Xiu-Qi Wang, Dong-Hua Yang & Zhe-Sheng Chen. (2016) Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells. Molecules 21:9, pages 1236.
Crossref
Sung-Han Hsiao, Yu-Jen Lu, Chun-Chiao Yang, Wei-Cherng Tuo, Yan-Qing Li, Yang-Hui Huang, Chia-Hung Hsieh, Tai-Ho Hung & Chung-Pu Wu. (2016) Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1. Journal of Natural Products 79:8, pages 2135-2142.
Crossref
Veronika F.S. Pape, Szilárd Tóth, András Füredi, Kornélia Szebényi, Anna Lovrics, Pál Szabó, Michael Wiese & Gergely Szakács. (2016) Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. European Journal of Medicinal Chemistry 117, pages 335-354.
Crossref
Sung-Han Hsiao, Yu-Jen Lu, Yan-Qing Li, Yang-Hui Huang, Chia-Hung Hsieh & Chung-Pu Wu. (2016) Osimertinib (AZD9291) Attenuates the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCB1 in Vitro. Molecular Pharmaceutics 13:6, pages 2117-2125.
Crossref
Zhiguang Ren, Xiaoke Gu, Bin Lu, Yaqiong Chen, Guojiang Chen, Jiannan Feng, Jizhen Lin, Yihua Zhang & Hui Peng. (2016) Anticancer efficacy of a nitric oxide‐modified derivative of bifendate against multidrug‐resistant cancer cells. Journal of Cellular and Molecular Medicine 20:6, pages 1095-1105.
Crossref
Jin Chen, Zheng-Min He, Feng-Ling Wang, Zheng-Sheng Zhang, Xiu-zhen Liu, Dan-Dan Zhai & Wei-Dong Chen. (2016) Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections. European Journal of Pharmacology 772, pages 33-42.
Crossref
Eduardo E. Chufan, Khyati Kapoor & Suresh V. Ambudkar. (2016) Drug–protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. Biochemical Pharmacology 101, pages 40-53.
Crossref
Raphael Koch, Thiha Aung, Daniel Vogel, Bjoern Chapuy, Dirk Wenzel, Sabrina Becker, Ursula Sinzig, Vivek Venkataramani, Tobias von Mach, Ralf Jacob, Lorenz Truemper & Gerald G. Wulf. (2016) Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone. Clinical Cancer Research 22:2, pages 395-404.
Crossref
Wei Chen, Fang Wang, Xu Zhang, Jing Hu, Xiaokun Wang, Ke Yang, Liyan Huang, Meng Xu, Qingshan Li & Liwu Fu. (2016) Overcoming ABCG2-mediated multidrug resistance by a mineralized hyaluronan–drug nanocomplex. Journal of Materials Chemistry B 4:41, pages 6652-6661.
Crossref
Suneet Shukla, Atish Patel & Suresh V. Ambudkar. 2016. ABC Transporters - 40 Years on. ABC Transporters - 40 Years on 227 272 .
LIANG DENG, DEJIAN LI, WENGUANG GU, AIGUO LIU & XIANGYANG CHENG. (2015) Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell line. Oncology Letters 10:5, pages 3323-3331.
Crossref
M.P. Ween, M.A. Armstrong, M.K. Oehler & C. Ricciardelli. (2015) The role of ABC transporters in ovarian cancer progression and chemoresistance. Critical Reviews in Oncology/Hematology 96:2, pages 220-256.
Crossref
Yang-Hui Huang, Sung-Han Hsiao & Chung-Pu Wu. (2015) Isoreserpine Reverses Multidrug Resistance Mediated by ABCB1. Journal of Cancer Research Updates 4:4.
Crossref
Magimairajan Issai Vanan & David D. Eisenstat. (2015) DIPG in Children – What Can We Learn from the Past?. Frontiers in Oncology 5.
Crossref
Elisabeta Baiceanu, Gianina Crisan, Felicia Loghin & Pierre Falson. (2015) Modulators of the human ABCC2: hope from natural sources?. Future Medicinal Chemistry 7:15, pages 2041-2063.
Crossref
Sharad S. Singhal, Jyotsana Singhal, James Figarola, David Horne & Sanjay Awasthi. (2015) RLIP76 Targeted Therapy for Kidney Cancer. Pharmaceutical Research 32:10, pages 3123-3136.
Crossref
Sheng-qi Wang, Shi-ting Liu, Bo-xin Zhao, Fu-heng Yang, Ya-tian Wang, Qian-ying Liang, Ya-bin Sun, Yuan Liu, Zhi-hua Song, Yun Cai & Guo-feng Li. (2015) Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1. Oncotarget 6:28, pages 26142-26160.
Crossref
Maurice Zandvliet & Erik Teske. (2015) Mechanisms of Drug Resistance in Veterinary Oncology— A Review with an Emphasis on Canine Lymphoma. Veterinary Sciences 2:3, pages 150-184.
Crossref
Hui Zhang, Xuanxuan Jing, Xiaojuan Wu, Jing Hu, Xiaofang Zhang, Xiao Wang, Peng Su, Weiwei Li & Gengyin Zhou. (2015) Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes. Anti-Cancer Drugs 26:7, pages 706-715.
Crossref
Daniela Cihalova, Frantisek Staud & Martina Ceckova. (2015) Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro. Cancer Chemotherapy and Pharmacology 76:1, pages 105-116.
Crossref
Kim S. Horger, Haiyan Liu, Divya K. Rao, Suneet Shukla, David Sept, Suresh V. Ambudkar & Michael Mayer. (2015) Hydrogel-assisted functional reconstitution of human P-glycoprotein (ABCB1) in giant liposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes 1848:2, pages 643-653.
Crossref
Lurong Pan & Stephen G. Aller. (2015) Equilibrated Atomic Models of Outward-Facing P-glycoprotein and Effect of ATP Binding on Structural Dynamics. Scientific Reports 5:1.
Crossref
Yanyan Zhang, Yidong Feng, Kodithuwakku Nandani Darshika, Bo Zhang, Yahui Hu, Weirong Fang, Yunman Li & Wenlong Huang. (2015) The effect of multidrug resistance modulator HZ08 on pharmacodynamics and pharmacokinetics of adriamycin in xenograft-nude mice. European Journal of Pharmaceutical Sciences 66, pages 109-117.
Crossref
Rishil J. Kathawala, Pranav Gupta, Charles R. AshbyJr.Jr. & Zhe-Sheng Chen. (2015) The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade. Drug Resistance Updates 18, pages 1-17.
Crossref
Sabina Dizdarevic & Adrien Michael Peters. 2015. Resistance to Targeted ABC Transporters in Cancer. Resistance to Targeted ABC Transporters in Cancer 133 151 .
Xiao-cong Huang, Priyank Kumar, Nagaraju Anreddy, Xue Xiao, Dong-Hua Yang & Zhe-Sheng Chen. 2015. Handbook of Anticancer Drugs from Marine Origin. Handbook of Anticancer Drugs from Marine Origin 593 619 .
Robert M. Greenberg. (2014) Schistosome ABC multidrug transporters: From pharmacology to physiology. International Journal for Parasitology: Drugs and Drug Resistance 4:3, pages 301-309.
Crossref
Xiaoke Gu, Zhiguang Ren, Hui Peng, Sixun Peng & Yihua Zhang. (2014) Bifendate-chalcone hybrids: A new class of potential dual inhibitors of P-glycoprotein and breast cancer resistance protein. Biochemical and Biophysical Research Communications 455:3-4, pages 318-322.
Crossref
Divya K. Rao, Haiyan Liu, Suresh V. Ambudkar & Michael Mayer. (2014) A Combination of Curcumin with Either Gramicidin or Ouabain Selectively Kills Cells That Express the Multidrug Resistance-linked ABCG2 Transporter. Journal of Biological Chemistry 289:45, pages 31397-31410.
Crossref
Nagaraju Anreddy, Pranav Gupta, Rishil Kathawala, Atish Patel, John Wurpel & Zhe-Sheng Chen. (2014) Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance. Molecules 19:9, pages 13848-13877.
Crossref
Jessica R. Vargas, Erika Geihe Stanzl, Nelson N. H. Teng & Paul A. Wender. (2014) Cell-Penetrating, Guanidinium-Rich Molecular Transporters for Overcoming Efflux-Mediated Multidrug Resistance. Molecular Pharmaceutics 11:8, pages 2553-2565.
Crossref
SUMEI LU, LIANG YU, YAKUI MU, JUKE MA, JIAJUN TIAN, WEI XU & HAIBO WANG. (2014) Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells. Molecular Medicine Reports 10:1, pages 53-60.
Crossref
Aditi M. Jhaveri & Vladimir P. Torchilin. (2014) Multifunctional polymeric micelles for delivery of drugs and siRNA. Frontiers in Pharmacology 5.
Crossref
Yi-Lung Ding, Yu-Hsuan Shih, Fu-Yuan Tsai & Max K. Leong. (2014) In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2). PLoS ONE 9:3, pages e90689.
Crossref
Ming Jia, Jing Hu, Weiwei Li, Peng Su, Hui Zhang, Xiaofang Zhang & Gengyin Zhou. (2014) Trps1 is associated with the multidrug resistance of osteosarcoma by regulating MDR1 gene expression. FEBS Letters 588:5, pages 801-810.
Crossref
HUI-QIN GUO, GUAN-NAN ZHANG, YI-JUN WANG, YUN-KAI ZHANG, KAMLESH SODANI, TANAJI T. TALELE, CHARLES R. ASHBYJrJr & ZHE-SHENG CHEN. (2014) β-elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter. Oncology Reports 31:2, pages 858-866.
Crossref
Ahmet UludagCoskun SilanSinem AtikCisem AkurutAysegul UludagFatma SilanOzturk Ozdemir. (2014) Relationship Between Response to Colchicine Treatment and MDR1 Polymorphism in Familial Mediterranean Fever Patients . Genetic Testing and Molecular Biomarkers 18:2, pages 73-76.
Crossref
Satyakam Singh, Nagarajan Rajendra Prasad, Khyati Kapoor, Eduardo E. Chufan, Bhargav A. Patel, Suresh V. Ambudkar & Tanaji T. Talele. (2014) Design, Synthesis, and Biological Evaluation of ( S )-Valine Thiazole-Derived Cyclic and Noncyclic Peptidomimetic Oligomers as Modulators of Human P-Glycoprotein (ABCB1) . ChemBioChem 15:1, pages 157-169.
Crossref
Erlong Zhang, Shenglin Luo, Xu Tan & Chunmeng Shi. (2014) Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent. Biomaterials 35:2, pages 771-778.
Crossref
Robert M. Greenberg. (2013) ABC multidrug transporters in schistosomes and other parasitic flatworms. Parasitology International 62:6, pages 647-653.
Crossref
Uwe Wenzel. (2013) Flavonoids as drugs at the small intestinal level. Current Opinion in Pharmacology 13:6, pages 864-868.
Crossref
Saurabh G. Vispute, Jun-Jiang Chen, Yue-Li Sun, Kamlesh S. Sodani, Satyakam Singh, Yihang Pan, Tanaji Talele, Charles R. Ashby Jr & Zhe-Sheng Chen. (2013) Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance. Journal of Cancer Research Updates 2:4.
Crossref
CONG WANG, LIU-BIN GUO, JUN-YUAN MA, YONG-MEI LI & HONG-MIN LIU. (2013) Establishment and characterization of a paclitaxel-resistant human esophageal carcinoma cell line. International Journal of Oncology 43:5, pages 1607-1617.
Crossref
Jens Pahnke, Christina Fröhlich, Markus Krohn, Toni Schumacher & Kristin Paarmann. (2013) Impaired mitochondrial energy production and ABC transporter function—A crucial interconnection in dementing proteopathies of the brain. Mechanisms of Ageing and Development 134:10, pages 506-515.
Crossref
Xiufen Cao, Fuli Feng, Yinsong Wang, Xiaoying Yang, Hongquan Duan & Yongshen Chen. (2013) Folic acid-conjugated graphene oxide as a transporter of chemotherapeutic drug and siRNA for reversal of cancer drug resistance. Journal of Nanoparticle Research 15:10.
Crossref
Jun-Jiang Chen, Atish Patel, Kamlesh Sodani, Zhi-Jie Xiao, Amit K. Tiwari, Dong-Mei Zhang, Ying-Jie Li, Dong-Hua Yang, Wen-Cai Ye, Si-Dong Chen & Zhe-Sheng Chen. (2013) BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10). PLoS ONE 8:9, pages e74573.
Crossref
Ilza K. Pajeva, Katja Sterz, Matthias Christlieb, Kerstin Steggemann, Federico Marighetti & Michael Wiese. (2013) Interactions of the Multidrug Resistance Modulators Tariquidar and Elacridar and their Analogues with P-glycoprotein. ChemMedChem, pages n/a-n/a.
Crossref
Kee W. Tan, Yan Li, James W. Paxton, Nigel P. Birch & Arjan Scheepens. (2013) Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food Chemistry 138:4, pages 2267-2274.
Crossref
Susanna J. E. Veringa, Dennis Biesmans, Dannis G. van Vuurden, Marc H. A. Jansen, Laurine E. Wedekind, Ilona Horsman, Pieter Wesseling, William Peter Vandertop, David P. Noske, GertJan J. L. Kaspers & Esther Hulleman. (2013) In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma. PLoS ONE 8:4, pages e61512.
Crossref
Jasna Banković, Jörg Andrä, Nataša Todorović, Ana Podolski-Renić, Zorica Milošević, Đorđe Miljković, Jannike Krause, Sabera Ruždijić, Nikola Tanić & Milica Pešić. (2013) The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: The unique way of multi-drug resistance modulation. Experimental Cell Research 319:7, pages 1013-1027.
Crossref
Limin Pan, Jianan Liu, Qianjun He, Lijun Wang & Jianlin Shi. (2013) Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials 34:11, pages 2719-2730.
Crossref
Stina Syvänen & Jonas Eriksson. (2012) Advances in PET Imaging of P-Glycoprotein Function at the Blood-Brain Barrier. ACS Chemical Neuroscience 4:2, pages 225-237.
Crossref
Chung-Pu Wu, Hong-May Sim, Yang-Hui Huang, Yen-Chen Liu, Sung-Han Hsiao, Hsing-Wen Cheng, Yan-Qing Li, Suresh V. Ambudkar & Sheng-Chieh Hsu. (2013) Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Biochemical Pharmacology 85:3, pages 325-334.
Crossref
Khyati Kapoor, Hong May Sim & Suresh V. Ambudkar. 2013. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy 1 34 .
Yan Xu, Feng Zhi, Guangming Xu, Xiaolei Tang, Sheng Lu, Jinhui Wu & Yiqiao Hu. (2012) Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416 . Bioscience Reports 32:6, pages 559-566.
Crossref
Inês Valente, Mariana Reis, Noélia Duarte, Julianna Serly, Joséph Molnár & Maria-José U. Ferreira. (2012) Jatrophane Diterpenes from Euphorbia mellifera and Their Activity as P-Glycoprotein Modulators on Multidrug-Resistant Mouse Lymphoma and Human Colon Adenocarcinoma Cells . Journal of Natural Products 75:11, pages 1915-1921.
Crossref
Dong-Mei Zhang, Chang Shu, Jun-Jiang Chen, Kamlesh Sodani, Jiao Wang, Jaya Bhatnagar, Ping Lan, Zhi-Xiong Ruan, Zhi-Jie Xiao, Suresh V. Ambudkar, Wei-Min Chen, Zhe-Sheng Chen & Wen-Cai Ye. (2012) BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo . Molecular Pharmaceutics 9:11, pages 3147-3159.
Crossref
Stefania Nobili, Ida Landini, Teresita Mazzei & Enrico Mini. (2011) Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression. Medicinal Research Reviews 32:6, pages 1220-1262.
Crossref
Rajendra PrasadAndre Goffeau. (2012) Yeast ATP-Binding Cassette Transporters Conferring Multidrug Resistance. Annual Review of Microbiology 66:1, pages 39-63.
Crossref
Hui Zhang, Xiaofang Zhang, Xiaojuan Wu, Weiwei Li, Peng Su, Hongxia Cheng, Lei Xiang, Peng Gao & Gengyin Zhou. (2012) Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway. Cancer Letters 323:1, pages 106-113.
Crossref
Ravi S. Kasinathan & Robert M. Greenberg. (2012) Pharmacology and potential physiological significance of schistosome multidrug resistance transporters. Experimental Parasitology 132:1, pages 2-6.
Crossref
Won Ki Kim, Ju-Hwa Kim, Kyungsil Yoon, Sunshin Kim, Jungsil Ro, Han Sung Kang & Sungpil Yoon. (2011) Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest. Investigational New Drugs 30:4, pages 1311-1318.
Crossref
Dipankar Pramanik, Nathaniel R. Campbell, Samarjit Das, Sonal Gupta, Venugopal Chenna, Savita Bisht, Polina Sysa-Shah, Djahida Bedja, Collins Karikari, Charles Steenbergen, Kathleen L. Gabrielson, Amarnath Maitra & Anirban Maitra. (2012) A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget 3:6, pages 640-650.
Crossref
Ying-Kiat Zee, Boon-Cher Goh & Soo-Chin Lee. (2012) Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacy. Future Oncology 8:6, pages 731-749.
Crossref
Anne Pick & Michael Wiese. (2012) Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway. ChemMedChem 7:4, pages 650-662.
Crossref
Max K. Leong, Hong-Bin Chen & Yu-Hsuan Shih. (2012) Prediction of Promiscuous P-Glycoprotein Inhibition Using a Novel Machine Learning Scheme. PLoS ONE 7:3, pages e33829.
Crossref
Jin-Ming Li, Yuan-Yuan Wang, Mei-Xia Zhao, Cai-Ping Tan, Yi-Qun Li, Xue-Yi Le, Liang-Nian Ji & Zong-Wan Mao. (2012) Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. Biomaterials 33:9, pages 2780-2790.
Crossref
Xiu-zhen Tong, Fang Wang, Shu Liang, Xu Zhang, Jie-hua He, Xing-Gui Chen, Yong-ju Liang, Yan-jun Mi, Kenneth Kin Wah To & Li-wu Fu. (2012) Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells. Biochemical Pharmacology 83:5, pages 586-597.
Crossref
Bin Xu, Jian Ding, Kai-Xian Chen, Ze-Hong Miao, He Huang, Hong Liu & Xiao-Min Luo. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy 287 350 .
Chung-Pu Wu, Chia-Hung Hsieh & Yu-Shan Wu. (2011) The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy. Molecular Pharmaceutics 8:6, pages 1996-2011.
Crossref
Hai-Guang Liu, Chong Chen, Han Yang, Yi-Fei Pan & Xiao-Hua Zhang. (2011) Cancer stem cell subsets and their relationships. Journal of Translational Medicine 9:1.
Crossref
Hong-May Sim, Chung-Pu Wu, Suresh V. Ambudkar & Mei-Lin Go. (2011) In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs. Biochemical Pharmacology 82:11, pages 1562-1571.
Crossref
Monika Sharma & Rajendra Prasad. (2011) The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans. Antimicrobial Agents and Chemotherapy 55:10, pages 4834-4843.
Crossref
Yan Li, Jezrael L. Revalde, Glen Reid & James W Paxton. (2010) Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer Chemotherapy and Pharmacology 68:3, pages 603-610.
Crossref
Raquel De Souza, Payam Zahedi, Rose M. Badame, Christine Allen & Micheline Piquette-Miller. (2011) Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer. Molecular Cancer Therapeutics 10:7, pages 1289-1299.
Crossref
W. Garrido, M. Muñoz, R. San Martín & C. Quezada. (2011) FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1. Biochemical and Biophysical Research Communications 411:1, pages 62-68.
Crossref
Dae-Young Kim, Mi-Ju Kim, Hak-Bong Kim, Jae-Won Lee, Jae-Ho Bae, Dong-Wan Kim, Chi-Dug Kang & Sun-Hee Kim. (2011) Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:7, pages 796-805.
Crossref
Xiao-Bing Xiong & Afsaneh Lavasanifar. (2011) Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin. ACS Nano 5:6, pages 5202-5213.
Crossref
Ting-Chun Kuo, Po-Cheng Chiang, Chia-Chun Yu, Kyoko Nakagawa-Goto, Kenneth F. Bastow, Kuo-Hsiung Lee & Jih-Hwa Guh. (2011) A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways. Biochemical Pharmacology 81:9, pages 1136-1144.
Crossref
Guohua An, Fang Wu & Marilyn E. Morris. (2011) 5,7-Dimethoxyflavone and Multiple Flavonoids in Combination Alter the ABCG2-Mediated Tissue Distribution of Mitoxantrone in Mice. Pharmaceutical Research 28:5, pages 1090-1099.
Crossref
Hong May Sim, Ker Yun Loh, Wee Kiang Yeo, Chong Yew Lee & Mei Lin Go. (2011) Aurones as Modulators of ABCG2 and ABCB1: Synthesis and Structure–Activity Relationships. ChemMedChem 6:4, pages 713-724.
Crossref
Anne Pick, Henrik Müller, Ralf Mayer, Britta Haenisch, Ilza K. Pajeva, Mathias Weigt, Heinz Bönisch, Christa E. Müller & Michael Wiese. (2011) Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). Bioorganic & Medicinal Chemistry 19:6, pages 2090-2102.
Crossref
Payam Zahedi, Raquel De Souza, Loan Huynh, Micheline Piquette-Miller & Christine Allen. (2010) Combination Drug Delivery Strategy for the Treatment of Multidrug Resistant Ovarian Cancer. Molecular Pharmaceutics 8:1, pages 260-269.
Crossref
Susan K. Murphy & Andrew Berchuck. 2011. Emerging Therapeutic Targets in Ovarian Cancer. Emerging Therapeutic Targets in Ovarian Cancer 223 244 .
Olga A Patutina, Nadezda L Mironova, Nelly A Popova, Vasily I Kaledin, Valery P Nikolin, Valentin V Vlassov & Marina A Zenkova. (2010) The siRNA targeted to mdr1b and mdr1a mRNAs in vivosensitizes murine lymphosarcoma to chemotherapy. BMC Cancer 10:1.
Crossref
Abdolhossein Zarrin, Ahmad R. Mehdipour & Ramin Miri. (2010) Dihydropyridines and Multidrug Resistance: Previous Attempts, Present State, and Future Trends. Chemical Biology & Drug Design 76:5, pages 369-381.
Crossref
Yan Xia & Kyeong Lee. (2010) Targeting Multidrug Resistance with Small Molecules for Cancer Therapy. Biomolecules and Therapeutics 18:4, pages 375-385.
Crossref
Pierluigi Nervi, Xiaochun Li-Blatter, Päivi Äänismaa & Anna Seelig. (2010) P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity. Biochimica et Biophysica Acta (BBA) - Biomembranes 1798:3, pages 515-525.
Crossref
Jeannie M. Padowski & Gary M. Pollack. 2010. Multi-Drug Resistance in Cancer. Multi-Drug Resistance in Cancer 359 384 .
Chow H. Lee. 2010. Multi-Drug Resistance in Cancer. Multi-Drug Resistance in Cancer 325 340 .
Katja Sterz, Lars Möllmann, Anna Jacobs, Dieter Baumert & Michael Wiese. (2009) Activators of P-glycoprotein: Structure-Activity Relationships and Investigation of their Mode of Action. ChemMedChem 4:11, pages 1897-1911.
Crossref
P Kannan, C John, S S Zoghbi, C Halldin, M M Gottesman, R B Innis & M D Hall. (2009) Imaging the Function of P-Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications. Clinical Pharmacology & Therapeutics 86:4, pages 368-377.
Crossref
Fei Shen, Barbara J. Bailey, Shaoyou Chu, Aimee K. Bence, Xinjian Xue, Priscilla Erickson, Ahmad R. Safa, William T. Beck & Leonard C. Erickson. (2009) Dynamic Assessment of Mitoxantrone Resistance and Modulation of Multidrug Resistance by Valspodar (PSC833) in Multidrug Resistance Human Cancer Cells. Journal of Pharmacology and Experimental Therapeutics 330:2, pages 423-429.
Crossref
Kazuma Maeno, Akio Nakajima, Gwenaëlle Conseil, Alice Rothnie, Roger G. Deeley & Susan P. C. Cole. (2009) Molecular Basis for Reduced Estrone Sulfate Transport and Altered Modulator Sensitivity of Transmembrane Helix (TM) 6 and TM17 Mutants of Multidrug Resistance Protein 1 ( ABCC1 ) . Drug Metabolism and Disposition 37:7, pages 1411-1420.
Crossref
Robert A. Terkeltaub. (2009) Colchicine Update: 2008. Seminars in Arthritis and Rheumatism 38:6, pages 411-419.
Crossref
Sharad S. Singhal, Jyotsana Singhal, Sushma Yadav, Mukesh Sahu, Yogesh C. Awasthi & Sanjay Awasthi. (2009) RLIP76: A Target for Kidney Cancer Therapy. Cancer Research 69:10, pages 4244-4251.
Crossref
Markus A. Seeger & Hendrik W. van Veen. (2009) Molecular basis of multidrug transport by ABC transporters. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1794:5, pages 725-737.
Crossref
Sharad S. Singhal, Cherice Roth, Kathryn Leake, Jyotsana Singhal, Sushma Yadav & Sanjay Awasthi. (2009) Regression of prostate cancer xenografts by RLIP76 depletion. Biochemical Pharmacology 77:6, pages 1074-1083.
Crossref
Suneet Shukla, Robert W. Robey, Susan E. Bates & Suresh V. Ambudkar. (2009) Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2. Drug Metabolism and Disposition 37:2, pages 359-365.
Crossref
Suneet Shukla, Hani Zaher, Anika Hartz, Björn Bauer, Joseph A. Ware & Suresh V. Ambudkar. (2008) Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice. Pharmaceutical Research 26:2, pages 480-487.
Crossref
David Torres-Romero, Francisco Muñoz-Martínez, Ignacio A. Jiménez, Santiago Castanys, Francisco Gamarro & Isabel L. Bazzocchi. (2009) Novel dihydro-β-agarofuran sesquiterpenes as potent modulators of human P-glycoprotein dependent multidrug resistance. Organic & Biomolecular Chemistry 7:24, pages 5166.
Crossref
Elaine M. Hurt, George J. Klarmann, Brian T. Kawasaki, Nima Sharifi & William L. Farrar. 2009. Stem Cells and Cancer. Stem Cells and Cancer 137 165 .
Teresa L. Serafim, Júlio A.C. Matos, Vilma A. Sardão, Gonçalo C. Pereira, Ana F. Branco, Sandro L. Pereira, Donna Parke, Edward L. Perkins, António J.M. Moreno, Jon Holy & Paulo J. Oliveira. (2008) Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells—Nuclear vs. mitochondrial effects. Biochemical Pharmacology 76:11, pages 1459-1475.
Crossref
Hong-May Sim, Chong-Yew Lee, Pui Lai Rachel Ee & Mei-Lin Go. (2008) Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein). European Journal of Pharmaceutical Sciences 35:4, pages 293-306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.